Eugenia L Kim, DO - Medicare Family Practice in Worthington, OH

Eugenia L Kim, DO is a medicare enrolled "Family Medicine" physician in Worthington, Ohio. She went to Ohio University, College Of Osteopathic Medicine and graduated in 2010 and has 14 years of diverse experience with area of expertise as Family Practice. She is a member of the group practice Central Ohio Primary Care Physicians, Inc. and her current practice location is 874 Proprietors Rd, Worthington, Ohio. You can reach out to her office (for appointments etc.) via phone at (614) 885-9405.

Eugenia L Kim is licensed to practice in Ohio (license number 34.010926) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1063732956.

Contact Information

Eugenia L Kim, DO
874 Proprietors Rd,
Worthington, OH 43085-3152
(614) 885-9405
(614) 885-9481



Physician's Profile

Full NameEugenia L Kim
GenderFemale
SpecialityFamily Practice
Experience14 Years
Location874 Proprietors Rd, Worthington, Ohio
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Eugenia L Kim attended and graduated from Ohio University, College Of Osteopathic Medicine in 2010
  NPI Data:
  • NPI Number: 1063732956
  • Provider Enumeration Date: 06/02/2010
  • Last Update Date: 07/16/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 7810134335
  • Enrollment ID: I20130729000505

Medical Identifiers

Medical identifiers for Eugenia L Kim such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1063732956NPI-NPPES
0086760MedicaidOH

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine 34.010926 (Ohio)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Ohiohealth Home HealthWorthington, OHHome health agency
Riverside Methodist HospitalColumbus, OHHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Central Ohio Primary Care Physicians, Inc.2769383785488

News Archive

Targeted molecular therapy reduces initial development of NAFLD in mice

Researchers report in the journal Cell Reports a targeted molecular therapy that dramatically reduces the initial development of Non Alcoholic Fatty Liver Disease (NAFLD) in laboratory mouse models of the disease.

People with higher Leptin levels have significantly reduced incidence of AD and dementia

This week's issue of the Journal of the American Medical Association (Dec 16) features a report on a long-term, prospective study of elderly, dementia-free individuals led by researchers from Boston University School of Medicine and the Framingham Heart Study focusing on the association between the protein hormone Leptin and the risk of developing Alzheimer's disease (AD).

NAPHS survey shows that need for psychiatric services in inpatient hospitals continues to grow

The need for psychiatric services in inpatient hospitals continues to grow, according to the latest annual survey from the National Association of Psychiatric Health Systems released today. The survey reports 2012 data that was collected in 2013 from NAPHS-member organizations. Data were analyzed and reported by Dobson DaVanzo & Associates, LLC, Vienna, VA.

MEI Pharma begins ME-344 Phase Ib clinical study in patients with solid tumors

MEI Pharma, Inc., an oncology company focused on the clinical development of novel therapies for cancer, announced today that the first patient has been dosed in a Phase Ib clinical study of its investigational mitochondrial inhibitor drug candidate ME-344 in combination with Hycamtin (topotecan) in patients with solid tumors, including small cell lung and ovarian cancers.

Researchers model probability of extinction of SARS-CoV-2 variant in an outbreak

However, it cannot be confirmed for certain that the strain has been eliminated, raising the question of how long a strain must go undetected before being considered, in all probability, extinct.

Read more Medical News

› Verified 8 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Eugenia L Kim allows following entities to bill medicare on her behalf.
Entity NameOhiohealth Corporation
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1578545273
PECOS PAC ID: 6305758426
Enrollment ID: O20031105000532

News Archive

Targeted molecular therapy reduces initial development of NAFLD in mice

Researchers report in the journal Cell Reports a targeted molecular therapy that dramatically reduces the initial development of Non Alcoholic Fatty Liver Disease (NAFLD) in laboratory mouse models of the disease.

People with higher Leptin levels have significantly reduced incidence of AD and dementia

This week's issue of the Journal of the American Medical Association (Dec 16) features a report on a long-term, prospective study of elderly, dementia-free individuals led by researchers from Boston University School of Medicine and the Framingham Heart Study focusing on the association between the protein hormone Leptin and the risk of developing Alzheimer's disease (AD).

NAPHS survey shows that need for psychiatric services in inpatient hospitals continues to grow

The need for psychiatric services in inpatient hospitals continues to grow, according to the latest annual survey from the National Association of Psychiatric Health Systems released today. The survey reports 2012 data that was collected in 2013 from NAPHS-member organizations. Data were analyzed and reported by Dobson DaVanzo & Associates, LLC, Vienna, VA.

MEI Pharma begins ME-344 Phase Ib clinical study in patients with solid tumors

MEI Pharma, Inc., an oncology company focused on the clinical development of novel therapies for cancer, announced today that the first patient has been dosed in a Phase Ib clinical study of its investigational mitochondrial inhibitor drug candidate ME-344 in combination with Hycamtin (topotecan) in patients with solid tumors, including small cell lung and ovarian cancers.

Researchers model probability of extinction of SARS-CoV-2 variant in an outbreak

However, it cannot be confirmed for certain that the strain has been eliminated, raising the question of how long a strain must go undetected before being considered, in all probability, extinct.

Read more Medical News

› Verified 8 days ago

Entity NameCentral Ohio Primary Care Physicians, Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1194705194
PECOS PAC ID: 2769383785
Enrollment ID: O20040114000204

News Archive

Targeted molecular therapy reduces initial development of NAFLD in mice

Researchers report in the journal Cell Reports a targeted molecular therapy that dramatically reduces the initial development of Non Alcoholic Fatty Liver Disease (NAFLD) in laboratory mouse models of the disease.

People with higher Leptin levels have significantly reduced incidence of AD and dementia

This week's issue of the Journal of the American Medical Association (Dec 16) features a report on a long-term, prospective study of elderly, dementia-free individuals led by researchers from Boston University School of Medicine and the Framingham Heart Study focusing on the association between the protein hormone Leptin and the risk of developing Alzheimer's disease (AD).

NAPHS survey shows that need for psychiatric services in inpatient hospitals continues to grow

The need for psychiatric services in inpatient hospitals continues to grow, according to the latest annual survey from the National Association of Psychiatric Health Systems released today. The survey reports 2012 data that was collected in 2013 from NAPHS-member organizations. Data were analyzed and reported by Dobson DaVanzo & Associates, LLC, Vienna, VA.

MEI Pharma begins ME-344 Phase Ib clinical study in patients with solid tumors

MEI Pharma, Inc., an oncology company focused on the clinical development of novel therapies for cancer, announced today that the first patient has been dosed in a Phase Ib clinical study of its investigational mitochondrial inhibitor drug candidate ME-344 in combination with Hycamtin (topotecan) in patients with solid tumors, including small cell lung and ovarian cancers.

Researchers model probability of extinction of SARS-CoV-2 variant in an outbreak

However, it cannot be confirmed for certain that the strain has been eliminated, raising the question of how long a strain must go undetected before being considered, in all probability, extinct.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Eugenia L Kim is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Eugenia L Kim, DO
874 Proprietors Rd,
Worthington, OH 43085-3152

Ph: (614) 885-9405
Eugenia L Kim, DO
874 Proprietors Rd,
Worthington, OH 43085-3152

Ph: (614) 885-9405

News Archive

Targeted molecular therapy reduces initial development of NAFLD in mice

Researchers report in the journal Cell Reports a targeted molecular therapy that dramatically reduces the initial development of Non Alcoholic Fatty Liver Disease (NAFLD) in laboratory mouse models of the disease.

People with higher Leptin levels have significantly reduced incidence of AD and dementia

This week's issue of the Journal of the American Medical Association (Dec 16) features a report on a long-term, prospective study of elderly, dementia-free individuals led by researchers from Boston University School of Medicine and the Framingham Heart Study focusing on the association between the protein hormone Leptin and the risk of developing Alzheimer's disease (AD).

NAPHS survey shows that need for psychiatric services in inpatient hospitals continues to grow

The need for psychiatric services in inpatient hospitals continues to grow, according to the latest annual survey from the National Association of Psychiatric Health Systems released today. The survey reports 2012 data that was collected in 2013 from NAPHS-member organizations. Data were analyzed and reported by Dobson DaVanzo & Associates, LLC, Vienna, VA.

MEI Pharma begins ME-344 Phase Ib clinical study in patients with solid tumors

MEI Pharma, Inc., an oncology company focused on the clinical development of novel therapies for cancer, announced today that the first patient has been dosed in a Phase Ib clinical study of its investigational mitochondrial inhibitor drug candidate ME-344 in combination with Hycamtin (topotecan) in patients with solid tumors, including small cell lung and ovarian cancers.

Researchers model probability of extinction of SARS-CoV-2 variant in an outbreak

However, it cannot be confirmed for certain that the strain has been eliminated, raising the question of how long a strain must go undetected before being considered, in all probability, extinct.

Read more News

› Verified 8 days ago


Family Medicine Doctors in Worthington, OH

Dr. Jeffrey L Hunter, D.O.
Family Medicine
Medicare: Medicare Enrolled
Practice Location: 445 E Granville Rd, Worthington, OH 43085
Phone: 614-293-2850    
Veronique Bartman, M.D.
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 160 W Wilson Bridge Rd, Worthington, OH 43085
Phone: 614-293-2850    Fax: 614-293-2849
Scott Michael Reineck, DO
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 874 Proprietors Rd, Worthington, OH 43085
Phone: 614-885-9405    Fax: 614-885-9481
Dr. Harkiran Singh, M.D.
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 160 W Wilson Bridge Rd, Worthington, OH 43085
Phone: 614-293-2850    Fax: 614-293-2849
Elizabeth S Unk, M.D.
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 874 Proprietors Rd, Worthington, OH 43085
Phone: 614-885-9405    Fax: 614-885-9481
John M Jonesco, D.O.
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 445 E Dublin Granville Rd, Worthington, OH 43085
Phone: 614-293-2850    Fax: 614-293-2849

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.